Contact us
CSR
Insud Pharma
Español
Toggle navigation
Company
About mAbxience
CEO message
Leadership team
Business development and commercial team
Business growth story
Our philosophy
Our locations
R&D
Design philosophy
Portfolio
Manufacturing
Argentina: mAbxience Buenos Aires – Garín
Argentina: mAbxience Buenos Aires – Munro
Spain: mAbxience León
Fill & finish partners
Partnerships
Partnerships
CDMO
Media
News
What’s next? meet us at…
Blog mAbxience
Join us
Company
About mAbxience
CEO message
Leadership team
Business development and commercial team
Business growth story
Our philosophy
Our locations
R&D
Design philosophy
Portfolio
Manufacturing
Argentina: mAbxience Buenos Aires – Garín
Argentina: mAbxience Buenos Aires – Munro
Spain: mAbxience León
Fill & finish partners
Partnerships
Partnerships
CDMO
Media
News
What’s next? meet us at…
Blog mAbxience
Join us
Contact us
CSR
Insud Pharma
Español
Contact us
CSR
Insud Pharma
Español
Toggle navigation
Company
About mAbxience
CEO message
Leadership team
Business development and commercial team
Business growth story
Our philosophy
Our locations
R&D
Design philosophy
Portfolio
Manufacturing
Argentina: mAbxience Buenos Aires – Garín
Argentina: mAbxience Buenos Aires – Munro
Spain: mAbxience León
Fill & finish partners
Partnerships
Partnerships
CDMO
Media
News
What’s next? meet us at…
Blog mAbxience
Join us
Company
About mAbxience
CEO message
Leadership team
Business development and commercial team
Business growth story
Our philosophy
Our locations
R&D
Design philosophy
Portfolio
Manufacturing
Argentina: mAbxience Buenos Aires – Garín
Argentina: mAbxience Buenos Aires – Munro
Spain: mAbxience León
Fill & finish partners
Partnerships
Partnerships
CDMO
Media
News
What’s next? meet us at…
Blog mAbxience
Join us
Contact us
CSR
Insud Pharma
Español
mAbxience |
Glossary
Find here all you need!
VIEW ALL
A - Z
Z - A
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Active ingredient (or active substance)
ANTIBODY
ANTIGEN
ANTIGEN DETERMINANT
ANTIGENITCITY
AVIDITY
B
BACTERIOPHAGE
BACULOVIRUS
BATCH CULTURE
BINDING
BIOACTIVITY
BIOAVAILABILITY
BIOEQUIVALENCE
BIOLOGICAL DRUGS
BIOPHARMACEUTICAL
BIOPROCESSING
BioSim
BIOSIMILAR
BIOSIMILARITY
BIOTECHNOLOGY
C
CBER
CELL BANK
CELL CULTURE
CELL HARVESTING
CELL LINE
cGMP
CHIMERIC TRANSGENE
CHMP
CLINICAL STUDY TRIAL
CLONE
COMPARABILITY
E
EMA
EXTRAPOLATION
F
FDA
FEED
FINGERPRINT-LIKE
FORMULATION
Fucosylation
G
GENE TRANSFER
GENETIC ENGINEERING
GLYCOSYLATION
GMP
H
HAPTEN
HIGH-AFFINITY ANTIBODY
HLA
I
IMMUNOGENICITY
INNOVATIVE REFERENCE DRUG
INTERCHANGEABILITY
M
Mab
MANUFACTURING SCALE PRODUCTION
Marketing authorisation
MCB (MASTER CELL BANK)
MEDIA
MONOCLONAL ANTIBODY (MAB)
O
ORIGINATOR COMPANY
OUTSOURCING ACTIVITIES
P
Patent
PERFORMACE QUALIFICATION
PHARMACODYNAMIC TEST
PHARMACOKINETIC TEST
PHARMACOVIGILANCE
Q
QUALITY
R
Risk management system
S
SIMILARITY
SINGLE-USE TECHNOLOGY
SUBSTITUTION
T
TRACEABILITY